Washington (AFP) – Israeli generic drug maker Teva has reached an agreement in principle to pay $4.25 billion over 13 years to settle a series of court cases over its role in the US opioid epidemic. If the deal is finalized, Teva would become the latest major company to reach a settlement over the crisis which caused hundreds of thousands of deaths and ravaged communities across the country. Teva reached the potential agreement on the terms of a “nationwide opioids settlement” with a working group of state attorneys general and lawyers for Native American tribes and other plaintiffs, the compa…